Azithromycin 500 mg tablets recalled over manufacturing violations
- Recall date
- April 29, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- PD-Rx Pharmaceuticals, Inc. recalls Azithromycin 500 mg tablets, Rx Only, packaged in a) 1 count, b) 2 count, c) 3 count, and d) 7 count bottles, Packaged…
- Recall number
- D-0561-2016
- FDA classification
- Class II
- Brand / firm
- PD-Rx Pharmaceuticals, Inc.
- Sold / distributed
- Nationwide
Why it was recalled
cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm did not adequately investigate customer complaints.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Azithromycin 500 mg tablets, Rx Only, packaged in a) 1 count, b) 2 count, c) 3 count, and d) 7 count bottles, Packaged by: PD-RX Pharmaceuticals, Inc., Oklahoma City, OK 73127, Mfr: Wokhardt Ltd., Mumbai, India, NDC: a) 55289-274-79, b) 55289-274-02, c) 55289-274-03, d) 55289-274-07.
Get recall alerts
Free email alert whenever PD-Rx Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: PD-Rx Pharmaceuticals, Inc.